Evaluation of Feasibility of Ultrasonography Guided Pulmonary Artery Catheterization in Pulmonary Hypertension Diagnosis
Evaluation of the Feasibility of Ultrasonography Guided Pulmonary Artery Catheterization in Pulmonary Hypertension Diagnosis.Pulmonary Artery Catheters (PACs) That Called Swan-Ganz Catheters Provide Valuable Information in Select Patient's Especially Pulmonary Hypertension Patiens. PACs Are Indicated for Assessment of Cardiopulmonary Hemodynamics in Specific Groups of Patients Presenting With Pulmonary Hypertension, Pulmonary Embolism or Shock [1]. They Can be Inserted at Bedside Under Sterile Conditions and Provide Valuable Information That Can Add Benefit for Measures Recorded With Transthor
1 other identifier
observational
35
0 countries
N/A
Brief Summary
Pulmonary artery catheters (PACs) that called Swan-Ganz catheters provide valuable information in select patient's especially pulmonary hypertension patiens. PACs are indicated for assessment of cardiopulmonary hemodynamics in specific groups of patients presenting with pulmonary hypertension, pulmonary embolism or shock \[1\]. They can be inserted at bedside under sterile conditions and provide valuable information that can add benefit for measures recorded with transthoracic echocardiography. The advancement of PACs in a patient is usually performed by flotation of a balloon tipped catheter under pressure waveform guidance. The balloon tip floats in blood and is directed into the pulmonary artery by the normal flow from superior vena cava and through the right heart chambers into pulmonary artery. The correct positioning is needed for safe use and accurate cardiopulmonary hemodynamics measurement. The use of blind approach of insertion can be challenging in patients with slow blood flow as pulmonary hypertension patients. The abnormal flow can induce the PAC to coil in cardiac chambers such as right atrium and right ventricle or be misdirected to the inferior vena cava. Repeated attempts to retract and redirect the catheter can increase the risk of complications and should be avoided \[2\]. The use of fluoroscopic guidance persists in these cases. Fluoroscopy when used alongside pressure waveform analysis has been noted to reduce the time to wedge, number of attempts and composite complication rate in patients undergoing pulmonary hemodynamic assessment. Also, fluoroscopy provides real time visualization that can lead to reduction of catheter malposition and ventricular arrhythmias. Unfortunately, it is not available in all pulmonary hypertension units for bedside insertion and hemodynamics evaluation. The use of fluoroscopy can led to unnecessary radiation exposure to both the patient and the procedure team. Sonographic guided pulmonary catheter insertion is interesting technique ; however it still needed to be studied in pulmonary hypertension patients in pulmonary hypertension unit
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 27, 2025
CompletedStudy Start
First participant enrolled
August 30, 2025
CompletedFirst Posted
Study publicly available on registry
September 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
September 4, 2025
August 1, 2025
1.3 years
August 27, 2025
August 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Success rate** of PAC placement using ultrasound guidance alone
Time to catheter placement (in minutes) * Incidence of complications (major and minor) * Accuracy of hemodynamic parameters compared to standard reference * Learning curve evaluation over time
procedure time from starting patient puncture till procedure end (PAC)
Eligibility Criteria
Pulmonary hypertension patients refered to our pulmonary hyperetnsion unit for PAC
You may qualify if:
- Adults (≥18 years)
- Clinically suspected PH referred for diagnostic RHC
- Informed consent provided
You may not qualify if:
- Hemodynamic instability requiring immediate intervention
- Poor echocardiographic window despite TTE/TEE
- Contraindications to catheterization
- Known intracardiac shunts or severe tricuspid regurgitation (if it impairs catheter tracking)
- iteria: -
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mostafa K. Ahmedlead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
mostafa K Ahmed, MD
Assiut University pulmonary hypertension Unit Chest Department
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assiut University Faculty of Medicine chest departement pulmonary hypertension Unit
Study Record Dates
First Submitted
August 27, 2025
First Posted
September 4, 2025
Study Start
August 30, 2025
Primary Completion (Estimated)
December 30, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
September 4, 2025
Record last verified: 2025-08